Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Hualien City, Hualien County, 97002, Taiwan
NCT Number: NCT07334938
The goal of this clinical trial is to determine whether far-infrared therapy and transcutaneous electrical nerve stimulation (TENS) can improve postoperative side effects in patients with head and neck cancer. The main questions this study aims to answer are:
Can far-infrared therapy and transcutaneous electrical nerve stimulation reduce pain and improve neck range of motion?
Can far-infrared therapy and transcutaneous electrical nerve stimulation reduce inflammation?
Researchers will compare three groups:
Group A: control group; Group B: transcutaneous electrical nerve stimulation; Group C: far-infrared therapy combined with transcutaneous electrical nerve stimulation, to evaluate differences in pain, neck range of motion, and inflammation.
Participants will receive the assigned intervention in the morning and evening for five consecutive days. Outcome measurements will be conducted on the first and fifth days.
This study is active but is not currently recruiting participants.
30 year–85 year
All sexes
Interventional
Not applicable
Hualien City, Hualien County, 97002, Taiwan
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Transcutaneous electrical nerve stimulation is applied to the neck region twice daily, in the morning and evening, for five consecutive days.
Far-infrared therapy is applied to the neck region twice daily, in the morning and evening, for five consecutive days.
Time frame: Preoperative baseline (before surgery), postoperative day 10, and postoperative day 15
Pain intensity will be assessed using a numeric rating scale (NRS), with scores ranging from 0 (no pain) to 10 (worst pain imaginable).
Time frame: Preoperative baseline (before surgery), postoperative day 10, and postoperative day 15
Active neck range of motion will be measured in degrees, including flexion, extension, bilateral rotation, and bilateral lateral flexion.
Time frame: Preoperative baseline (before surgery), postoperative day 10, and postoperative day 15
Inflammatory markers will be calculated from complete blood counts, including the Lymphocyte-to-monocyte ratio(LMR) and neutrophil-to-lymphocyte ratio (NLR)
Buddhist Tzu Chi General Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05520099
Adenocarcinoma, Bladder Cancer
Little Rock, Arkansas, United States
View Trial DetailsNCT07431346
Dysgeusia, Head and Neck Cancer (H&N)
Brussels, Belgium
View Trial DetailsNCT07426874
Head and Neck Cancer (H&N), Head and Neck Neoplasms
Beaumont, Ireland
View Trial DetailsNCT07705074
Adenocarcinoma, Adenoma
Baden, Canton of Aargau, Switzerland
View Trial Details